
Congo Ebola Treatment Trial Puts Hope and Trust at the Centre of the Response
A new trial in eastern Congo testing remdesivir and the antibody treatment MBP134 is a test of whether science, local trust and logistics can move fast enough.
The latest Ebola news, headlines and analysis from The NE Times.

A new trial in eastern Congo testing remdesivir and the antibody treatment MBP134 is a test of whether science, local trust and logistics can move fast enough.

The country's health minister ordered work stopped on a quarantine site amid a contempt finding and public opposition, exposing tensions over sovereignty and health security.

Health ministry says contacts are being traced and the risk to the European public is very low, as attention turns to hospital isolation procedures and cross-border readiness.

Health officials in the Democratic Republic of the Congo say the eastern outbreak has reached 1,003 confirmed cases and 254 deaths, with insecurity and crowded camps complicating the response.